Jury Biotech/Life Sciences Investor Panel

Felice Verduyn- van Weegen | Partner | EQT Life Sciences

Felice Verduyn-van Weegen is a Partner in the EQT Life Sciences team. Felice worked for LSP from 2015 until 2022, when LSP joined forces with EQT and was renamed EQT Life Sciences. Felice is on several company boards for EQT life sciences, including Agomab, Amolyt pharma and Evommune. Prior to joining LSP, Felice worked as a consultant at McKinsey & Company in Amsterdam, Netherlands. Prior to McKinsey, Felice was a neuroscientist and statistical geneticist, working with the prestigious complex traits genetics group at the Broad Institute and Harvard Medical School in Cambridge, USA. Felice holds a MSc degree in Neuroscience from VU University Amsterdam and an MBA degree from Columbia Business School in New york

About EQT Life Sciences

EQT Life Sciences, formerly LSP, is one of Europe’s largest and most experienced healthcare investors, targeting innovative life sciences and health care companies. With a track record going back 30 years, EQT Life Sciences has raised more than €3 billion, and invested in over 150 private companies. With a dedicated team of highly experienced investment professionals, coming from backgrounds in medicine, science, and industry, EQT Life Sciences backs the smartest inventors who have ideas that could truly make a difference for patients. The team combines deep sector knowledge, analytical skills, and investment experience to provide the added value that inventors seek.